Zhengduozhe Technology Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ZDZT research report →
Price Chart
About the company
Zhengduozhe Technology Inc. , operating as DAKOTA Life Sciences, is a biopharmaceutical enterprise dedicated to the acquisition, development, and commercialization of therapeutic agents. These pharmaceuticals are specifically engineered to prevent and treat severe medical conditions encountered in both clinical and community environments.
- CEO
- Jingwei Zhang
- IPO
- 1995
- HQ
- Yichun, CN
Get TickerSpark's AI analysis on ZDZT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $23.37K
- P/E
- -0.14
- PEG
- 0.00
- P/S
- 0.27
- P/B
- 0.46
- EV/EBITDA
- -0.00
- Div Yield
- 0.00%
- Gross Margin
- -1708.90%
- Op Margin
- -7629.59%
- Net Margin
- -7547.85%
- ROE
- -27073.10%
- ROIC
- 940.58%
Latest fiscal year · YoY change
- Revenue
- $306.19K+33.1%
- Gross Profit
- $21.60K-74.1%
- Op Income
- $-63,262
- Net Income
- $-63,262-182.1%
- EPS
- $-0.00-178.9%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $1.92
- 52W Low
- $0.55
- 50D MA
- $0.57
- 200D MA
- $0.79
- Beta
- 6.22
- RSI (14)
- 34
- Avg Volume
- 17
No earnings-call transcripts are available for ZDZT yet.
- Free Float
- 0.0%
- Shares Outstanding
- 41.14K
- Float Shares
- 0
Our ZDZT coverage
Recent articles, reports, and earnings notes.
No research on ZDZT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ZDZT report →